
Harmony Biosciences Presents Promising Preclinical Data for Novel Narcolepsy Treatment
PLYMOUTH MEETING, PA — Harmony Biosciences recently revealed compelling preclinical data for BP1.15205, a highly potent and selective orexin 2 receptor (OX2R) agonist, at the 39th Annual Meeting of the …
Harmony Biosciences Presents Promising Preclinical Data for Novel Narcolepsy Treatment Read More